Success Metrics

Clinical Success Rate
92.9%

Based on 26 completed trials

Completion Rate
93%(26/28)
Active Trials
3(8%)
Results Posted
19%(5 trials)
Terminated
2(5%)

Phase Distribution

Ph phase_2
6
15%
Ph not_applicable
32
80%
Ph phase_4
1
3%

Phase Distribution

0

Early Stage

6

Mid Stage

1

Late Stage

Phase Distribution39 total trials
Phase 2Efficacy & side effects
6(15.4%)
Phase 4Post-market surveillance
1(2.6%)
N/ANon-phased studies
32(82.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

92.9%

26 of 28 finished

Non-Completion Rate

7.1%

2 ended early

Currently Active

3

trials recruiting

Total Trials

40

all time

Status Distribution
Active(5)
Completed(26)
Terminated(2)
Other(7)

Detailed Status

Completed26
unknown7
Recruiting3
Terminated2
Not yet recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
40
Active
3
Success Rate
92.9%
Most Advanced
Phase 4

Trials by Phase

Phase 26 (15.4%)
Phase 41 (2.6%)
N/A32 (82.1%)

Trials by Status

unknown718%
not_yet_recruiting13%
recruiting38%
completed2665%
enrolling_by_invitation13%
terminated25%

Recent Activity

Clinical Trials (40)

Showing 20 of 40 trialsScroll for more
NCT07515443Not Applicable

The Effects of a Commercially Available Synbiotic on the Gut Microbiome and Cardiometabolic Health

Completed
NCT07694791Not Applicable

Probiotic and Prebiotic Supplementation in Peritoneal Dialysis Patients

Recruiting
NCT05282485Not Applicable

Mitigating Infectious Morbidity and Growth Deficits in HIV Exposed Uninfected infanTs With Human Milk Oligosaccharides

Completed
NCT06300060Not Applicable

Synbiotic Supplementation in Cyclists

Completed
NCT07453823Not Applicable

The Effect of a Synbiotic on Intestinal Barrier Function and Microbiota Modulation in Middle-aged to Elderly Individuals With Excessive Body Weight

Recruiting
NCT06901739Not Applicable

Therapeutic Potential of a Synbiotic to Improve Mental Health in Subjects With Obesity.

Recruiting
NCT07048470Not Applicable

Efficacy of Synbiotic Supplementation on IL-10, TGF-B and Disease Activity in Systemic Lupus Erythematosus Patients

Completed
NCT06480812Not Applicable

The Role of Synbiotics in Modulating Host Physiology Via the Gut Microbiome

Completed
NCT06722443Not Applicable

Impact of Nutritional Intervention With Probiotics and Prebiotics on Obesity.

Enrolling By Invitation
NCT06396689Not Applicable

NapBiome: Targeting Gut Microbiota and Sleep Rhythm to Improve Developmental and Behavioral Outcomes in Early Childhood

Not Yet Recruiting
NCT04097106

Synbiotic Dietary Supplement and Gut Microbiota

Completed
NCT04804046Not Applicable

Synbiotics and Post-op Crohn's Disease

Terminated
NCT06160830Not Applicable

The Effects of Synbiotic on Cardiovascular and Bone Metabolism Markers in Transplanted Kidney Patients

Unknown
NCT04639141Not Applicable

Combined Gut-brain Therapy for Children With Autism

Completed
NCT03907501Not Applicable

Effects of Triphala and VSL#3 Probiotic Supplementation on Stool Microbiome Profiles and Inflammation

Terminated
NCT05180201Phase 2

SEPSIS: L. Plantarum Trial

Completed
NCT05405205Not Applicable

Effect of Synbiotic L. Fermentum Strains on Body Fat Mass

Unknown
NCT04754464Not Applicable

Clinical Study on the Effect of a Synbiotic on Body Fat Mass

Completed
NCT05162209Not Applicable

PROBESITY-2: Synbiotics in Pediatric Obesity

Completed
NCT02124759Phase 2

Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim 1)

Completed

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
40